Suggestions
Sophia Nnenna Ononye, PhD MPH MBA
Yale-trained Breast Cancer Research Scientist| Entrepreneur| Podcaster| Speaker| Certified Corporate Director| Board Advisor| Women's Health/FemTech Strategist| NMQF 40 under 40 Minority Health Leader| Author| Mentor
Professional Background
Dr. Sophia Nnenna Ononye, PhD MPH MBA, is a remarkable figure in the fields of breast cancer research and women's health, boasting an impressive career that spans academia, entrepreneurship, and corporate leadership. As a Yale-trained research scientist specializing in triple-negative breast cancer (TNBC), she brings a wealth of knowledge to her work as an educator, thought leader, and consultant. Currently, Dr. Ononye serves as the owner and principal of The Sophia Consulting Firm (SCF), a consultancy dedicated to scientific communications and executive leadership that is proud to be 100% woman- and minority-owned.
In June 2024, she made a significant impact in the literary world by launching the first volume of her consultancy's flagship book series, titled "Leadership Perspectives on Scientific Innovation: Volume 1." This work reflects her commitment to amplifying scientific innovation and fostering leadership that contributes to health equity and informed healthcare decision-making.
As the creator, host, and producer of SCF's video podcast series, "Amplifying Scientific Innovation®," launched during the height of the COVID-19 pandemic, Dr. Ononye has successfully established a credible platform for science advocacy and health equity discussions. This initiative not only underscores her passion for educating the public but also showcases her expertise in navigating complex health issues.
Education and Achievements
Dr. Ononye's educational credentials are as impressive as her professional achievements. She holds a PhD in Medicinal Chemistry and an MBA in Healthcare Management from the University of Connecticut. Additionally, she earned a Master of Public Health (MPH) in Public Health Administration from The University of Toledo, alongside an Honors Bachelor of Science (BS) in Chemistry with a specialization in Biochemistry from Bowling Green State University. Her academic journey was further enriched by postdoctoral training in Medical Oncology at the esteemed Yale School of Medicine.
Throughout her illustrious career, Dr. Ononye has received numerous accolades that highlight her contributions to health equity and leadership. Among her significant honors are the 2023 National Minority Quality Forum's 40 under 40 Minority Health Leader Award, recognition at the Nasdaq closing bell in 2022 as one of the pioneering National Association of Corporate Directors Certified Directors, and being named a Commetric Top Digital Health Influencer (FemTech) in 2021. Additionally, she has been honored with multiple awards from the Healthcare Businesswomen's Association (HBA), including the Mentor Award and the Spark Award in 2020.
Notable Contributions
Beyond her consultancy work, Dr. Ononye's experience extends to several prestigious roles across various organizations. She has served as an Entrepreneur in Residence at Chapman University and Yale Ventures, providing guidance to emerging entrepreneurs in the healthcare field. Her tenure as a Board Advisor at Daré Bioscience, Inc., and as a former Independent Board Director, where she was an active member of the Nomination and Corporate Governance and Compensation Committees, underscores her strategic involvement in innovative healthcare solutions.
Dr. Ononye's leadership qualities have also shone through her position as Executive Vice President and Managing Director at Rx Medical Dynamics (RXMD), her role as Director of Healthcare Practice at The Beacon Group under Accenture, and her previous work as Head of Corporate Communications/Investor Relations at OncoSec. Her commitment to women in business is evident in her service as National Student Director at the National Association of Women MBAs (NAWMBA). Moreover, Dr. Ononye has contributed to education as an Adjunct Professor of Chemistry at Goodwin College and Central Connecticut State University, sharing her passion for science and healthcare with the next generation of leaders.
Dr. Ononye's scientific acumen was also exemplified during her time as an Associate Analytical Development Scientist at Pfizer, where she played an integral role in advancing medical research and drug development. This breadth of experience makes her a sought-after speaker and mentor, as she is dedicated to empowering others, particularly women and minorities, who aspire to make their mark in science and corporate leadership.
As a published author, podcaster, and speaker, Dr. Ononye brings awareness to the importance of health equity, scientific innovation, and leadership in science. Her work continues to inspire many, particularly in the realms of women's health and FemTech, where she is at the forefront of making a difference.
Achievements
- NMQF 40 under 40 Minority Health Leader Award (2023)
- Nasdaq Closing Bell Recognition as one of the First 1,000 National Association of Corporate Directors Certified Directors (2022)
- Commetric Top Digital Health Influencer (FemTech) (2021)
- HBA Mentor Award (2020)
- HBA Spark Award (2020)
